Cyprotex PLC
(“Cyprotex” or the “Company”)
Rule 2.10 Announcement
Pursuant to Rule 2.10 of the City Code on Mergers and Acquisitions (the "Code"), Cyprotex confirms that it has 178,957,188 ordinary shares of 0.1p each ("Ordinary Shares"), in issue and admitted to trading on the AIM market of the London Stock Exchange. The International Securities Identification Number for the ordinary shares is GB0031214470.
Rule 19.11 disclosure
In accordance with Rule 19.11 of the Code, a copy of this Announcement will be published on the Cyprotex website: www.cyprotex.com.
Enquiries:
Cyprotex PLC
Anthony Baxter CEO
01625 505100
ir@cyprotex.com
www.cyprotex.com
Execution Noble & Company Limited
John Llewellyn-Lloyd / Sam Reynolds
020 7456 9191
Public Relations
Financial Dynamics
Ben Brewerton / Ben Atwell / John Dineen
020 7831 3113
Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683
Email:
enquiries@cyprotex.com